A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation (2020)
Attributed to:
MICA: RIP1 kinase inhibition to reduce kidney injury
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1681/asn.2019121328
PubMed Identifier: 32238473
Publication URI: http://europepmc.org/abstract/MED/32238473
Type: Journal Article/Review
Parent Publication: Journal of the American Society of Nephrology
Issue: 5
ISSN: 1046-6673